Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Systolic blood pressure
研究概览
简要总结
This study will be conducted to investigate the effect of DASH diet and Progressive muscle relaxation on cardiovascular risks in postmenopausal women.
详细描述
Cardiovascular disease is the leading cause of morbidity and mortality in men and women, but the incidence of cardiovascular disease related deaths is higher in women than men. Hypertension is one of the leading risk factors for cardiovascular disease. Aging in both men and women is characterized by increases in blood pressure (BP), but the age-related increases are more rapid in women particularly postmenopausal women than in men.
A variety of non-pharmacologic treatments to manage stress have been found effective in reducing blood pressure and the development of hypertension. The DASH eating pattern promotes blood pressure reduction by encouraging the consumption of foods that are low in saturated fat, total fat, cholesterol, and sodium and high in potassium, calcium, magnesium, fiber, and protein. In terms of actual food choices, the DASH eating pattern encourages whole grains, fat free or low-fat dairy products, fruits, vegetables, poultry, fish, and nuts. Foods that are limited include fatty meats, full-fat dairy products, tropical oils (e.g., coconut, palm, and palm kernel oils), and sweets and sugar sweetened beverages.
The mechanism by which relaxation techniques lower blood pressure is unclear. One theory suggests that they may help lower the stress and physiologic arousal produced by the autonomic nervous system, thereby reducing blood pressure. So this study is a trial to determine the effect of DASH diet and progressive muscle relaxation in reducing cardiovascular risks in postmenopausal women.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 50 Years 至 60 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •The participant's ages will be ranged from 50- 60 years old.
- •Their body mass index will be ranged from 30-35 kg/m
- •All women are hypertensive at least one year postmenopause.
- •Their scores in perceived stress scale will be ranged from 14-40.
排除标准
- •Women with systolic blood pressure (SBP) >160 mmHg or diastolic blood pressure (DBP) >100mmHg.
- •Women who have other known causes of hypertension, such as renal diseases.
- •Women who are using sedatives or tranquilizer or antidepressant drugs.
研究组 & 干预措施
DASH diet group
The participants will be treated with the DASH diet and antihypertensive drugs
干预措施: Anti hypertensive drugs (Drug)
Progressive muscle relaxation group
The participants will be treated with progressive muscle relaxation and antihypertensive drugs
干预措施: Progressive muscle relaxation (Other)
DASH diet group
The participants will be treated with the DASH diet and antihypertensive drugs
干预措施: DASH diet (Dietary Supplement)
Progressive muscle relaxation group
The participants will be treated with progressive muscle relaxation and antihypertensive drugs
干预措施: Anti hypertensive drugs (Drug)
DASH diet and progressive muscle relaxation group
The participants will be treated with DASH diet and progressive muscle relaxation in addition to antihypertensive drugs
干预措施: DASH diet (Dietary Supplement)
DASH diet and progressive muscle relaxation group
The participants will be treated with DASH diet and progressive muscle relaxation in addition to antihypertensive drugs
干预措施: Progressive muscle relaxation (Other)
DASH diet and progressive muscle relaxation group
The participants will be treated with DASH diet and progressive muscle relaxation in addition to antihypertensive drugs
干预措施: Anti hypertensive drugs (Drug)
结局指标
主要结局
Systolic blood pressure
时间窗: 3 months
A sphygmomanometer will be used to measure systolic blood pressure (mmHg) for all participants in all groups before and after the treatment program
Diastolic blood pressure
时间窗: 3 months
A sphygmomanometer will be used to measure systolic blood pressure (mmHg) for all participants in all groups before and after the treatment program
Low density lipoprotein
时间窗: 3 months
Blood analysis will be used to measure level of low-density lipoprotein (mg/dl) for all participants in all groups before and after the treatment program. Its normal value is less than 100 mg/dl.
High density lipoprotein
时间窗: 3 months
Blood analysis will be used to measure level of high-density lipoprotein (mg/dl) for all participants in all groups before and after the treatment program. Its normal value is from 40 to more than 60 mg/dl.
Triglyceride level
时间窗: 3 months
Blood analysis will be used to measure the level of triglycerides (mg/dl) for all participants in all groups before and after the treatment program. Its normal value is less than 150 mg/dl.
Total cholesterol level
时间窗: 3 months
Blood analysis will be used to measure level of total cholesterol (mg/dl) for all participants in all groups before and after the treatment program. Its normal value is up to 200 mg/dl.
次要结局
- Stress measurement(3 months)
研究者
Farahnaz Ahmed Mohamed
Principal investigator
Cairo University
